News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
ARPA-H puts up $125M to bankroll personalized RNA-based drug production
Seattle-based HDT Bio is one of five teams selected by the Advanced Research Projects Agency for Health (ARPA-H) to share up to $125 million in
Just – Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
Just – Evotec Biologics has advanced JST-018, an investigational antibody treatment targeting orthopoxviruses, into a first-in-human Phase 1 clinical trial. Developed under a U.S. Department
Seattle science powerhouses bet big on AI-designed biology
A nearly $95 million Seattle research effort will use artificial intelligence to design biological molecules that do not exist in nature, with potential applications ranging
As U.S.-China biotech race heats up, Seattle makes its case to D.C.
Seattle life sciences leaders told the National Security Commission on Emerging Biotechnology that the region has strong scientific innovation but needs greater domestic manufacturing capacity
Benaroya Research Institute Awarded 16 Million Across 18 Grants in First Half of 2026 to Predict, Prevent, Reverse and Cure Immune System Diseases
Seattle-based Benaroya Research Institute (BRI) received 18 research grants totaling more than $16.2 million during the first half of 2026. The funding will support new
Seattle longevity startups unite: Viome acquires plasma exchange pioneer Circulate Health
Two Seattle-area health and longevity startups are joining forces as Viome Life Sciences acquires Circulate Health in a deal valued between $15 million and $50
Executive Perspective: Cultivating Scientific Excellence at Lundbeck
Mary Jo Phoenix is Vice President, Analytical Development and Quality Control at Lundbeck Seattle BioPharmaceuticals in Bothell, Washington. She reflects on her career in Washington’s
Kirkland’s EIT Pharma Announces Milestone for Drug Treating Chronic Hepatitis D
Kirkland-based EIT Pharma announced that the FDA has accepted its New Drug Application for Lonafarnib, an investigational oral treatment for chronic hepatitis D. The life-threatening
InduPro raises $77 million, begins first human trial of cancer drug
Biotech startup InduPro, with operations in Seattle and Cambridge, Mass., raised $77 million in Series B funding as it begins a Phase 1 clinical trial
Gates Foundation gives $540 million to UW health institute, the largest gift in university history
The Gates Foundation is giving $540.2 million to the University of Washington’s Institute for Health Metrics and Evaluation (IHME), marking the largest charitable gift in
Shape Therapeutics and Rett Syndrome Research Trust Announce Partnership to Advance a One-Time AI-Designed RNA Editing Therapy for Rett Syndrome
Seattle-based Shape Therapeutics announced a partnership with the Rett Syndrome Research Trust (RSRT) to advance SHP-401, an investigational one-time gene therapy for Rett syndrome. Under
Moving faster than planned, AI drug developer Accipiter Bio quietly tops up seed round with $10.5M
Seattle-based Accipiter Biosciences raised an additional $10.5 million from existing investors less than a year after emerging from stealth with $12.7 million in funding and